GlassScriptPhysician profile
Michael Steven Mckee
NPI 1124043625
$2,981.92
in general payments reported to CMS, 2019-2025
33 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,208 · 2020: $205 · 2021: $204 · 2022: $366.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $321.19 | 2019-2022 | |
| Novo Nordisk INC | $262.35 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $248.42 | 2019-2022 | |
| Glaxosmithkline, LLC. | $232.83 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $171.23 | 2019-2020 | |
| Amgen INC. | $161.41 | 2019-2020 | |
| Abbvie INC. | $161.22 | 2019-2022 | |
| Allergan, INC. | $159.36 | 2019-2020 | |
| Astellas Pharma US INC | $156.65 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $137.02 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $136.63 | 2019 | |
| Lilly USA, LLC | $112.98 | 2019-2022 | |
| Amarin Pharma, INC. | $97.44 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $84.96 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $79.50 | 2019-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $65.82 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $64.61 | 2019 | |
| Supernus Pharmaceuticals, INC. | $35.77 | 2019 | |
| Radius Health, INC. | $32.26 | 2019 | |
| Avanir Pharmaceuticals, INC. | $31.18 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $30.04 | 2021 | |
| Scilex Pharmaceuticals INC. | $29.79 | 2019 | |
| Janssen Pharmaceuticals, INC | $26.61 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.89 | 2019 | |
| Horizon Therapeutics Plc | $16.74 | 2019 | |
| Antares Pharma, INC. | $16.00 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $15.70 | 2021 | |
| Valeritas, INC. | $14.15 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $13.21 | 2019 | |
| Abbott Laboratories | $12.96 | 2020 | |
| Circassia INC. | $12.69 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.50 | 2022 | |
| Ironshore Pharmaceuticals INC. | $11.81 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mckee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.